Search Results 521-530 of 21271 for anti-TNF drugs

1. Triamcinolone (Topical Application Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Aristocort A; Cinolar; Dermasorb TA Complete Kit; Kenalog ...

2. Mycophenolate (Oral Route) Description and Brand Names - Mayo Clinic

   It is used with other medicines (eg, cyclosporine, steroid medicine) to lower the body's natural immunity in patients who receive kidney transplants.

3. Lithium (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

4. Artemether And Lumefantrine (Oral Route) Description and Brand Names - Mayo Clinic

   Artemether and lumefantrine combination belongs to a group of medicines known as antimalarials. It treats malaria, a red blood cell infection transmitted by ...

5. Infectious diseases - Diagnosis & treatment - Mayo Clinic

   More-severe internal organ fungal infections, especially in people with weakened immune systems, may require intravenous antifungal medications. Anti-parasitics.

6. Corticosteroid (Dental Route) Description and Brand Names - Mayo Clinic

   Descriptions. Dental corticosteroids are used to relieve the discomfort and redness of some mouth and gum problems. These medicines are like cortisone. They ...

7. Some pain medicines may increase heart attack risk after surgery - Mayo Clinic News Network

   In a McGill University study published recently in the British Medical Journal, researchers found that post-surgery use of nonsteroidal anti-inflammatory drugs ...

8. Milk thistle - Mayo Clinic

   Milk thistle may affect how your liver processes this osteoporosis medication, causing higher levels of the drug in your bloodstream. Talk to your doctor before ...

9. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

   Patient is currently receiving anti-TNF treatment for ≤12 months. Patient must receive anti-TNF treatment within 2 months following enrollment into the ...

10. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

    Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...